The purpose of this structured, evidence-based, clinical update was to determine if rapid sequence induction is a safe or effective technique to decrease the risk of aspiration or other complications of airway management.
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étaient classées comme RCT. Des pronostics définitifs, tels que la prévention d'une inhalation et les bienfaits par rapport à la mortalité, n'ont pas pu être évalués à partir des études. De même, l'impact sur les devenirs indésirables des différentes composantes de la RSI n'a pas pu être déterminé.

Conclusion
Clinical context for literature review
While on duty in your hospital, you are called to manage the airway of a woman with a suspected subarachnoid bleed. She is 45 yr old and was previously well aside from a history of intermittent gastroesophageal reflux that she treated with antacids when symptomatic. Following your assessment, you determine that she requires emergent airway management with endotracheal intubation. You believe that tracheal intubation to isolate the respiratory from the gastrointestinal tract is considered to be the optimum method to prevent aspiration in at-risk patients. Limiting the time that the airway is unprotected during the induction of anesthesia is intuitively advisable and the practice of rapid sequence induction (RSI) with cricoid pressure is widely accepted as the standard of care in this setting. 1 As you contemplate the intervention, you wonder what evidence is available to measure the impact of RSI on the incidence of aspiration, how it should best be performed, and what is its risk-to-benefit profile. These questions are particularly relevant in light of the marked increase use of RSI in situations outside of the operating room. The purpose of this article is to review the current evidence base supporting the use of RSI and its various components in at-risk patients.
Methods
In June 2006 a structured search of MEDLINE from 1966 to present using OVID software was undertaken with the assistance of a reference librarian. The primary question was whether RSI had any impact on the incidence, severity or consequences of pulmonary aspiration. Medical subject headings and text words describing rapid sequence induction or intubation, crash induction or intubation, cricoid pressure and emergency airway intubation were employed (Appendix 1). OVID's therapy (sensitivity) algorithm was used to maximize the detection of randomized trials while excluding non-randomized research. The search was restricted to articles written in English or French. The bibliographies of eligible publications were then hand-searched to identify trials not identified in the electronic search. The two investigators independently reviewed the abstracts of the trials to identify eligible research. Additional trials were identified with a similar technique to investigate and answer secondary questions (Table I) .
It was readily apparent that any conclusions addressing the primary question would be inadequately supported due to the limited number of studies, most of which were retrospective in nature. As well, the working definition of RSI used by researchers was variable and many of its component parts were of unproven or questionable merits. Thus, we sought to determine whether RSI had measurable benefits beyond aspiration prophylaxis and whether or not a risk-benefit relationship of the component parts of the RSI could be assessed using a list of secondary questions (Table  I) . This search included studies conducted by nonanesthesiologists and patients in a non-operative setting. In fact, much of the available literature comes from these sources. Although how well this information can be translated to the operative setting may be debatable, the goal of this review was to assess RSI and the various aspects of this technique using the best available literature. The literature review did not exclude pediatric or obstetrical studies but the recommendations mainly pertain to the non-obstetrical adult population.
The definition of RSI is variable and inconsistent in the literature. Though originally described as rapid or crash induction, 2, 3 RSI was called rapid sequence intubation in 182 of the 488 articles identified, and rapid sequence induction in 286, while 20 papers used both terms interchangeably (Appendix 1). For the purpose of our review and discussion, we defined RSI as it would be conventionally carried out by practicing What is the preferred preoxygenation technique for RSI? 3.
Should all drugs be rapidly administered during RSI? 4.
Which is the best induction drug for RSI? 5.
Which muscle relaxant should be used for RSI? 6.
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anesthesiologists. The technique evaluated includes preoxygenation, rapid administration of predetermined doses of both induction and paralytic drugs, concurrent application of cricoid pressure, avoidance of bag and mask ventilation, and direct laryngoscopy followed by tracheal intubation. One hundred and eighty-four eligible studies were identified using the described search strategy (Figure) . There were 163 randomized controlled trials (RCTs). The number of clinical trials that evaluated different drug regimens was 126 with 114 being RCTs. Twenty-one clinical trials evaluated non-pharmacologic aspects of RSI with 18 RCTs identified. In a parallel search, there were 52 trials solely evaluating cricoid pressure (outside of the context of an RSI technique) with 44 RCTs identified. The literature was independently ranked by the authors using the Oxford Center for Evidence Based Medicine criteria for both level of evidence and strength of recommendation (Appendices 2 and 3).
Results
Aspiration in contemporary anesthetic practice -incidence and risk factors
Contemporary reports from analysis of large databases demonstrate an overall incidence of aspiration of 1:2,000-3,000 patients administered general anesthesia. Aspiration is more frequent in emergency (1:600-900 cases) than elective (1:3,000-4,000) procedures. [4] [5] [6] The factor most commonly associated with an increased incidence of aspiration is emergency surgery. [4] [5] [6] [7] [8] The risk of aspiration also increases directly with increasing ASA physical status; there is a sevenfold increase in risk as ASA status increases from I to IV or V. 6, 8 Aspiration-associated morbidity also increases with ASA status and most deaths due to aspiration occur in ASA IV and V patients. Other factors often cited as being associated with a higher incidence of aspiration perioperatively include a history of reflux and hiatus hernia, obesity, difficult intubation, extremes of age, reduced level of consciousness, underlying neurological diseases, gastric obstruction, ileus and bowel obstruction, the recent ingestion of a meal, and critical illness.
4,6-12
Answering the primary question -the impact of RSI in aspiration prevention
The prevention of aspiration and its related complications by RSI is the primary outcome of interest as this is the reason for performing RSI. However, a number of factors make it difficult to employ aspiration as the outcome variable in studies assessing the impact of RSI. Aspiration is rare and very large numbers of patients would need to be studied to assess the impact of RSI on its occurrence. Morbidity and mortality would also be relevant outcomes for analysis but they are again uncommon and this analysis would also require very large numbers of patients to be studied. For practical reasons, surrogate outcomes, such as ease or success of intubation with RSI, are the most commonly reported, with successful tracheal intubation being the single most common outcome reported in clinical evaluations of RSI protocols. Further, many of the reports assessing RSI outcomes are simulations of RSI conducted in healthy elective populations who may not be representative of the cohorts of patients typically subjected to RSI. Following our analysis of the literature it was apparent that there was no evidence available that would allow the following question to be answered: "Does RSI reduce either the incidence or the adverse consequences of aspiration during emergency airway management?" In fact, there is no study, randomized, controlled, blinded, or otherwise, that measures the impact of any intervention on the incidence of aspiration, nor is there likely to be a statistically meaningful study conducted on this issue. Assuming that the incidence of aspiration during emergency surgery is 0.15%, 13 a strategy that would simply reduce the incidence by 50% would require a study of approximately 50,000 patients to confirm that benefit (onetailed hypothesis for improved outcome, α = 0.05, β = 0.20). Thus, the strength of any recommendation favouring the use of RSI for the prevention of aspiration would be Grade D.
Since an evidence-based conclusion regarding the efficacy and safety of RSI as it relates to aspiration or mortality is not possible, the only literature evalua- tion possible is a determination of the other potential benefits of RSI and a risk benefit assessment of the component parts of RSI as defined in Table I 14 Surprisingly, induction or sedative drugs were not used in either group with only topical local anesthetic and vasoconstrictor used in the blind nasal group. One hundred percent of the succinylcholineassisted direct oral intubations were successful, vs 65% of the blind nasal intubations. Mean time to intubation was shorter with succinylcholine and more of the patients in the succinylcholine-assisted group were intubated in < 120 sec. The number of intubation attempts and the complications recorded were also lower with succinylcholine-assisted intubation compared with nasal intubation.
There are three prospective, observational studies evaluating the outcomes between RSI, oral intubation with no sedation, oral intubation with sedation only, and/or blind nasal intubation in emergency room patients. [15] [16] [17] Two studies, including one multicentre analysis involving more than 6,000 patients, demonstrated a higher probability of success with RSI than with the other techniques, both on the first attempt and overall (estimated at 85% vs 75% for first attempt; and 92% vs 82% overall). 15, 16 The third report demonstrated that the application of RSI was successful as a rescue technique in all 102 cases where tracheal intubation had failed after being attempted initially orally, with or without sedation, or by blind nasal intubation. 17 None of these three studies analyzed adverse events related to the technique of intubation. There is also one prospective observational study comparing the complications of emergency intubation with and without the use of neuromuscular blocking agents (NMBA). 18 Complications, both minor and severe, were more common in the patients who were managed without NMBA than in those who were paralyzed to facilitate intubation (78% vs 28%, P < 0.0001). Finally, there are three retrospective studies that assess the impact of the introduction of an RSI protocol on intubation success in aeromedical transport. [19] [20] [21] All three reports documented an increase in the rate of intubation success with fewer intubation attempts and more rapid achievement of intubation with RSI compared with non-NMBA techniques.
Enthusiasm for widespread implementation of RSI protocols is however tempered by the sobering results of studies demonstrating increased mortality and morbidity. The San Diego Paramedic RSI Trial 22 prospectively evaluated the implementation of paramedic performed RSI in head injured patients compared with historic controls. Patients undergoing RSI performed by paramedics had increased mortality (33.0% vs 24.2%, P < 0.01) and lower incidence of a favourable outcome (45.5% vs 57.9%, P < 0.01) than controls managed without intubation. A retrospective assessment of the implication of a RSI protocol for air medical personnel by Falcone et al. 23 significantly increased transport times without improving intubation success rates. Ochs et al. 24 reported only an 84.2% intubation success rate after implementation of paramedic performed RSI. Although this success rate may be higher than with non-paralytic based techniques, it is debatable if the risks of paralysis are acceptable if there is a 15% failure rate. 25 In the prehospital and emergency room settings, the use of RSI is more likely to result in successful intubation, in less time, and with fewer attempts than will oral or nasal intubation techniques that do not involve the administration of muscle relaxants (Grade B recommendation). However, there is conflicting evidence regarding the incidence of complications and patient outcomes with airway interventions in the prehospital setting and strong recommendations regarding the application of RSI or other techniques in the field cannot be supported at this time.
What is the preferred preoxygenation technique for RSI?
The purpose of preoxygenating a patient before RSI is to provide the maximum duration that a patient can safely tolerate apnea so that airway interventions may be undertaken at low threat to the patient, even in situations where unanticipated difficulties arise. 26 It is assumed that the conventional pattern of practice is to refrain from bag-mask ventilation of the lungs in the interval from induction of anesthesia until laryngoscopy and tracheal intubation is performed. A number of outcome variables have been utilized in studies assessing the effectiveness of various preoxygenation techniques. These outcomes include: highest arterial oxygen tension (P a O 2 ) achieved; highest fractional end-tidal oxygen (F ET O 2 ) concentrations achieved; pulmonary nitrogen washout; and time to pulse oxygen desaturation (S p O 2 ) to a critical endpoint (defined by the authors as safe apnea time). Although there is generally a correlation between oxygen stores and safe apnea times, the most meaningful outcome of interest appears to be the time to a critical oxygen desaturation threshold after induction of anesthesia. The preferred oxygenation technique would thus be the one that provides the longest safe apnea time and the literature was evaluated on this basis. Two strategies have been advocated to provide preoxygenation, tidal volume ventilation (TVV) for three to five minutes (TVV3 -TVV5) or inspiration of a number of deep or vital capacity breaths (DB) over a shorter period of time.
Two RCTs investigated whether preoxygenation before induction of anesthesia improved the tolerance to apnea. 27, 28 Both demonstrated that preoxygenation prolonged the time to desaturation milestones and decreased the incidence of hypoxemia during the apneic intervals assessed. Five RCTs reported no difference on oxygen tensions generated with TVV three to five minutes compared with 4DB in 30 sec. [29] [30] [31] [32] [33] Four of these studies measured P a O 2 as the outcome variable and one measured the F ET O 2 ; safe apnea time was not assessed. However, three other RCTs dispute these results; each of these studies compared 4DB with TVV3 and measured safe apnea time. [34] [35] [36] All three reported that the time to desaturate to a given S p O 2 was longer when patients were preoxygenated with TVV than with DB techniques. Two subsequent RCTs have compared the effect of more prolonged period of deep breathing (8DB) with 4DB and TVV. 32, 33 Both concluded that 8DB was more effective than 4DB and as good or better than TVV3; one study measured safe apnea time 33 and the other reported F ET O 2 . 32 Two RCTs have measured the impact of maximal exhalation on subsequent preoxygenation. 37, 38 The measured outcomes were P a O 2 and F ET O 2 , rather than safe apnea time but both studies reported better outcomes when preoxygenation was preceded by maximal exhalation.
The role of patient positioning during preoxygenation was assessed in two RCTs in morbidly obese patients. 39, 40 Both studies measured safe apnea time after RSI and tracheal intubation and concluded that preoxygenation in a head-up position extends the safe apnea time in obese patients when compared with the supine position.
Preoxygenation of the patient before RSI provides substantial benefit with respect to increasing oxygen stores and extending the duration of safe apnea time following induction. Level 1b evidence supports the conclusion that TVV for at least three minutes or 8DB in 60 sec provides similar durations of safe apnea time (Grade A recommendation). Preoxygenation of obese patients in the head up position compared with the supine position also provides more prolonged safe apnea time after induction and is also supported by level 1b evidence (Grade A recommendation). The use of maximal exhalation before preoxygenation results in increased pulmonary oxygen concentrations; although no data are available regarding safe apnea time at present, it should be considered in cooperative patients (Grade B recommendation).
Should all drugs be rapidly administered during RSI?
Conscious patients with intact airway reflexes are able to protect their airways from gastric regurgitation but will not permit airway manipulation. As consciousness is lost (excluding normal sleep states), protection from gastric regurgitation is also lost. Further, most intravenous induction drugs and opioids reduce esophageal sphincter tone, thus increasing the risk of regurgitation. 41, 42 The goal of RSI therefore is to achieve a state that allows tracheal intubation but minimizes the time that patients are at risk for regurgitation and aspiration. The generally accepted practice regarding drug administration during RSI is rapid administration of predetermined doses. This practice may result in drug over-or under-dosing precipitating hemodynamic instability. If the hemodynamic consequences of bolus drug administration are severe, they may result in adverse outcomes negating any potential benefit of RSI.
There are no data that allow for a comparison of the risks of a more prolonged interval of reduced airway reflexes before tracheal intubation is achieved resulting from titrated drug administration vs the potential for hemodynamic instability resulting from rapid drug administration. Thus, level 5 evidence would suggest that rapid drug administration should be restricted to circumstances and patients with a high risk of aspiration and low potential for untoward responses to rapid drug administration (Grade D recommendation).
Which is the best induction drug for RSI?
The ideal induction drug for RSI would be a shortacting agent, free of adverse hemodynamic effects, effective at blunting the sympathetic response to intubation, that reliably ensures anesthesia and amnesia, improves the grade of laryngoscopy in the setting of inadequate paralysis, and is free of other adverse effects. A review of the literature indicates clearly that a single ideal induction drug for all RSI situations does not exist. All presently available induction drugs have problems or limitations associated with their use. Hypotension, due in large part to the rapid administration of induction drugs, has become the most common complication after emergent intubation. 15, [43] [44] [45] The challenge of selecting the best induction drug for RSI is further confounded by the marked heterogeneity of patient characteristics and clinical scenarios. Therefore, the evidence was evaluated to determine not only if one drug is best overall but also how induction drugs are presently used and if certain agents may be preferable in certain circumstances to others.
A survey of anesthetists in the UK suggests that thiopental, propofol and etomidate are the induction agents most commonly used for an RSI. 46 The National Emergency Airway Registry phase 2 (NEAR 2) reported that US emergentologists preferred the use of etomidate for RSI (69% of cases) with midazolam and fentanyl the next most commonly used induction drugs (16% and 6% respectively). 15 This prospective, multicentre registry initiated in January 1996 provides observational information on airway interventions performed in affiliated emergency departments in the United States, Canada and Singapore. Observations regarding RSI from NEAR 2 report successful intubation using RSI was achieved in 98.5% of patients with 83% success on initial attempt and 12% on the second. 15 Only 9.1% of patients received more than one drug labelled as sedative by the NEAR 2 investigators, although two-thirds of patients also received lidocaine. 15 The use of thiopental, methohexital and propofol were independent predictors of successful intubation on the first attempt. 15 Conversely, etomidate, ketamine and midazolam were less likely to be associated with successful single attempt intubations. The reported difference was attributed to a deeper plane of anesthesia achieved with the barbiturates and propofol that complemented incomplete muscle relaxation although no supporting evidence for this attribution was provided. 15 Studies directly comparing induction drugs for RSI using real emergency conditions are limited both in number and format. The best available study is the SHRED study, a blinded RCT comparing the use of thiopental (5 mg·kg ) and fentanyl (5 µg·kg -1 ) in 86 patients requiring intubation in the emergency department. 47 Outcomes were mortality, time until intubation, ease of intubation and hemodynamic stability during the procedure. Induction doses were reduced by 50% if patients were considered to be 'unstable' (heart rate > 100 min -1 or systolic blood pressure < 90 mmHg). Despite an overall 24% in-hospital mortality, no differences between groups were found, probably a reflection of the small sample size. The hemodynamic profile was most stable in the fentanyl group but significant hypotension still occurred in 21 of 86 patients. The thiopental group had the largest decrease in blood pressure (mean of 38 mmHg) but the highest rate of rapid intubation (intubation within 300 sec from start of protocol and within three attempts) compared with the two other agents. The midazolam-treated group was more likely to be deemed inadequately sedated by physicians compared with either the fentanyl or thiopental groups but this difference did not reach significance (6 vs 2 vs 1; P = 0.08). Therefore, level 2b evidence from NEAR and SHRED would suggest that thiopental is the single best overall induction drug (Grade C recommendation). Midazolam does not appear to have clear indications and its role as a sole induction agent for RSI must be questioned (Grade B recommendation).
Analysis of the features of the various induction drugs employed in RSI techniques, with respect to the characteristics of an ideal induction drug outlined above, yields the following results. With the possible exception of midazolam and fentanyl, the commonly used induction drugs including thiopental, propofol, etomidate, ketamine and methohexital all have reasonably short durations of action. Duration of action between these medications are unlikely to be different clinically and thus would not likely influence choice of induction agent for RSI. Likewise, there is insufficient evidence to determine if any of the induction drugs are better or worse for ensuring reliable amnesia or anesthesia. However, fentanyl is an unreliable drug for amnesia and anesthesia and thus cannot be recommended as a sole induction agent for RSI (Grade D recommendation).
Hemodynamic effects of the various induction drugs differ considerably. Etomidate induces minimal hemodynamic changes even in the setting of preexisting hypotension or significant cardiovascular disease. [48] [49] [50] [51] Significant decreases in blood pressure occur with thiopental although it is less apt to cause hypotension than propofol. [52] [53] [54] [55] Ketamine's stimulating effect on sympathetic output minimizes the hypotension with its use and provides more favourable hemodynamic effects compared with the other induction drugs with the exception of etomidate. Although hypotension and other life threatening complications are not prevented by etomidate use, 50, 56, 57 etomidate is the preferred drug for patients with limited cardiac reserve or in hemodynamic compromise (Grade C recommendation). Concerns surrounding etomidate's suppression of adrenal cortical function however remain [58] [59] [60] and caution is advised with avoidance in patients at risk for sepsis (Grade D recommendation).
The ability to effectively blunt the hypertensive reflex to intubation is particularly important in patients at risk for increased intracranial pressure (ICP). Administration of etomidate does not effectively blunt this reflex. 15, 48, 61 Barbiturates possess cerebral protective effects, but do not reliably block the hypertensive response to intubation. 15, 53, 62 Midazolam has neither effective sympathetic blunting effects nor cerebroprotective effects and should not be used in these circumstances. 15, 63 Ketamine increases ICP by a small amount, and it should be used with caution in patients at risk for neurologic injury. Propofol, as a single agent, is the most effective at suppressing the hypertensive response to intubation but it does not do so in a completely reliable fashion. 64, 65 No induction agent given alone is adequate for patients with increased ICP who are at risk for a hypertensive response to intubation (Grade C recommendation).
If complete muscle paralysis is provided, the effect of an induction drug on the laryngoscopy grade becomes a non-issue. However, in the setting of incomplete paralysis, added blunting of airway and laryngeal reflexes by an induction drug may improve laryngoscopy grade and intubation success. Ketamine tends to preserve these reflexes while etomidate and the barbiturates do not reliably blunt them. 15, 53, 62 Conversely, propofol is the most effective at blunting airway reflexes and is the preferred induction drug for improving laryngoscopy grade. [47] [48] [49] 52, 64, [66] [67] [68] [69] [70] [71] [72] Propofol is the preferred induction drug when a non-depolarizing NMBA is used and the use of propofol is not otherwise contraindicated (Grade A recommendation).
Which muscle relaxant should be used for RSI?
Succinylcholine has been the conventional choice for muscle relaxant for RSI. Motivated by concerns regarding the potential adverse effects of succinylcholine, a number of authors have assessed whether a non-depolarizing NMBA could provide intubating conditions in a similar time frame for RSI as succinylcholine but in the absence of adverse effects. Advocates for succinylcholine use during RSI primarily base their support on two factors: 1) its speed of onset; and 2) the perception that its duration of action is sufficiently short to allow recovery before oxygen desaturation in the event of failure to intubate the trachea. The validity of this latter assumption was, until recently, not tested.
The dose of succinylcholine necessary for excellent intubation conditions within 60 sec during simulated RSI was determined in a RCT which enrolled patients electively presenting for general anesthesia in non-urgent conditions. 73 Succinylcholine 0.39 mg·kg -1 and 1.6 mg·kg -1 provided excellent intubating conditions in 50% and 80% of patients studied at 60 sec, respectively. The dose required to provide acceptable intubation conditions in 95% of patients within 60 sec was also determined in a similar RCT. 74 Succinylcholine 0.24 mg·kg -1 and 0.56 mg·kg -1 provided acceptable intubating conditions in 90% and 95% of patients studied at 60 sec, respectively. Reducing the dose of succinylcholine from 1.0 to 0.60 mg·kg -1 decreased its duration of action by more than 90 sec, but onset times did not differ and intubation conditions were similar with all doses > 0.5 mg·kg -1 .
75,76
Apnea time, however was dose-dependent and the time to regular spontaneous reservoir bag movements was shorter in patients who received 0.6 mg·kg -1 (4.0 min) compared with patients given 1 mg·kg -1 (6.16 min). 76 The short duration of action of succinylcholine compared with non-depolarizing NMBAs has been considered by some to be an advantage should unexpected difficulties with laryngoscopy or ventilation be encountered. The hypothesis is that patients will recover from the effects of succinylcholine and resume spontaneous ventilation before the onset of critical hemoglobin desaturation [defined as a pulse oximetry (S p O 2 ) reading that is < 80% and decreasing] 77 thus avoiding the consequences of a cannot-intubate, cannot-ventilate scenario. Until recently, this hypothesis had not been tested with scientific rigor. Recovery from the effects of succinylcholine has been defined with a number of measures including a return of some fraction of the twitch response at the adductor pollicis, onset of diaphragmatic movement, recovery of spontaneous respiration with either reservoir bag movement or recordable end-tidal CO 2 , and eye opening. The recovery of spontaneous breathing has been termed functional recovery and is estimated to occur at about the same time as 50% recovery of twitch height; this takes an average of 8.5 min after a dose of succinylcholine 1 mg·kg -1 provided that the airway is patent. 77 It is the authors' opinion that functional recovery is the most meaningful clinical measure of recovery and the literature was evaluated on that basis. Critical desaturation will occur more quickly in a number of situations including obesity, increased oxygen consumption, inadequate preoxygenation, critical illness and an obstructed airway. 77, 78 One observational study enrolling 12 healthy volunteers assessed the time to recovery and the impact on hemoglobin saturation with apnea following the administration of succinylcholine 1 mg·kg , the facemask was removed and the airway left unsupported, simulating failed ventilation. In four volunteers (25%), the time to recovery of spontaneous respiration averaged seven minutes (five, seven, eight, nine minutes) and oxygen saturation (S p O 2 ) deteriorated to < 80% in all of them, requiring airway interventions. Two RCTs have assessed both the time to recovery and the impact on hemoglobin saturation following the administration of succinylcholine 1 mg·kg -1 . 73, 80 In one RCT, the facemask was removed during apnea and the airway was left unsupported. 73 The time to spontaneous diaphragmatic movement was 4.7 + 1.3 min and the S p O 2 deteriorated to < 90% in 85% of the patients. In the second RCT, the airway was supported and the facemask remained in place and was connected to an oxygen source during the apneic period. 80 The average times to diaphragmatic movement, reservoir bag movement, and a recordable ETCO 2 were 4.66 min, 4.7 min, and 5.06 min, respectively; in 11% of patients, S p O 2 decreased to < 90% before resumption of spontaneous ventilation.
To address the concern that critical desaturation may occur in some patients after administration of succinylcholine 1 mg·kg -1 if airway management difficulties are encountered, four RCTs have evaluated the effects of smaller doses of succinylcholine (< 1 mg·kg -1 ) on both intubating conditions and recovery; not all have used functional recovery as the index of recovery. 75, 76, 81 One RCT compared the impact on intubating conditions and recovery when administering succinylcholine in doses of 0.4, 0.6, and 1.0 mg·kg -1 . 75 The 0.6 and 1.0 mg·kg -1 doses produced similar degrees of relaxation but the mean time to twitch recovery of 90% was prolonged in the 1.0 mg·kg -1 dose group (9.3 + 1.2 min) compared with the 0.6 mg·kg -1 dose group (7.6 + 1.6 min). The authors acknowledged considerable overlap in the individual recovery times between the two groups and functional recovery was not measured. Two RCTs comparing functional recovery after doses of approximately 0.6 mg·kg -1 and 1.0 mg·kg -1 have yielded conflicting results. 76, 81 In the first study enrolling 20 patients in each group, the average time to spontaneous diaphragmatic movement was not different in patients who had received 0.56 mg·kg -1 (4.8 + 2.5 min) compared with 1.0 mg·kg -1 (4.7 + 1.3 min). 81 In the second RCT, enrolling 23 patients in each group, the average time to spontaneous diaphragm movement was longer in patients receiving 1.0 mg·kg -1 (5.3 + 0.8 min) than in those receiving 0.6 mg·kg -1 (4.0 + 0.5 min). 76 The time to resumption of spontaneous respiration as denoted by a well-formed ETCO 2 trace took an average of 35 sec beyond resumption of spontaneous diaphragm movement in the 0.6 mg·kg -1 group and 54 sec in the 1.0 mg·kg -1 group. The use of non-depolarizing NMBA has also been advocated to eliminate succinylcholine-related complications in RSI; the bulk of the current literature in this regard addresses the use of rocuronium. The majority of studies comparing succinylcholine and rocuronium used the achievement of good or excellent conditions and the occurrence of failed intubation as their principal outcome variables. However, failed intubation has not been common in patients treated with either succinylcholine or rocuronium and differences between the groups in this regard are rarely reported. A meta-analysis evaluating whether rocuronium provided intubating conditions equivalent to succinylcholine during RSI intubation included 26 RCTs and controlled clinical trials comparing rocuronium > 0.6 mg·kg -1 and succinylcholine > 1.0 mg·kg -1 .
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Succinylcholine was more likely than rocuronium to provide excellent intubating conditions although there was no difference when the less stringent endpoint of acceptable (excellent or good, not failed) conditions were measured. Again, there were few failed intubations in the studies, and no differences between the two agents in this regard were reported. Conditions were also more likely to be equivalent in studies that employed propofol for induction. The conclusions were that succinylcholine provided excellent intubating conditions more often than rocuronium 0.6-0.7 mg·kg -1 but rocuronium doses of 0.9-1.2 mg·kg -1
were more likely to be equivalent to succinylcholine. 69 Three subsequent RCTs provide additional support for these conclusions regarding the use of rocuronium for RSI. 52, 67, 82 Level 1a evidence support the conclusion that the paralytic drug of choice for RSI should continue to be succinylcholine as it is more likely to provide excellent intubating conditions in a shorter time frame than does rocuronium (Grade A recommendation). A dose > 1 mg·kg -1 is required to ensure excellent intubating conditions; doses < 0.5 mg·kg -1 are more often associated with poor intubating conditions (level 1b). A dose > 0.6 mg·kg -1 is associated with a similar measure of acceptable conditions as is 1 mg·kg -1 and may result in shorter apnea times but the evidence is conflicting; the duration of effect of either may result in hypoxemia if the patient cannot be intubated or oxygenated through bag-mask ventilation. Rocuronium, at a dose > 0.6 mg·kg -1 , is as likely to provide acceptable conditions when compared to succinylcholine but will less frequently provide excellent conditions; it is an acceptable alternative to succinylcholine for RSI if the latter is contraindicated or unavailable (Grade A rec-ommendation). Intubation conditions achieved with rocuronium are better if propofol is used and the use of propofol is advocated if there are no contraindications to its use (Grade A recommendation).
Should adjuvant drugs be routinely employed during RSI?
In addition to induction and paralytic drugs, several different drugs have been advocated for use during RSI. These so-called adjuvant drugs are typically used to blunt the potential for autonomic reflexes in response to intubation and to reduce both the dose and the adverse effects of the larger doses of the primary induction agent. Of the many different adjuvant drugs available, the administration of opioids, lidocaine, and esmolol are the most commonly described. 46, 47 Opioids appear to improve control of intraocular, intracranial and hemodynamic variables including attenuation of the hypertensive response to intubation. 64, 83 Although not appropriate as a sole induction drug because of the unreliable amnestic and general anesthetic effects, 84 fentanyl use in the SHRED study provided the most neutral hemodynamic profile post-intubation. 15 Lidocaine administered intravenously prior to intubation is reputed to diminish airway reactivity, the hypertensive response to intubation, and the rise in ICP. [85] [86] [87] However, three RCTs failed to demonstrate an effect for lidocaine in attenuating the cardiovascular responses to intubation in patients undergoing induction of general anesthesia. [88] [89] [90] As well, the evidence available on the efficacy of lidocaine for intubation in status asthmaticus or head injury does not support its use in these scenarios. 87, 91, 92 Esmolol is a short acting beta-blocker that appears to be more effective than lidocaine or fentanyl for suppressing the pressor response to intubation. 88, 93, 94 Level 1b evidence therefore supports the use of adjuvant drug including esmolol or opioids during RSI when a clinical assessment dictates a role (Grade A recommendation). Although lidocaine can suppress the cough reflex and may have an induction agent sparing effect, 95,96 level 2 evidence does not support its routine use for RSI (Grade B recommendation).
Should cricoid pressure be used routinely in all patients undergoing RSI?
Application of cricoid pressure (CP) or Sellick's maneuver is considered to be an integral component of RSI. 1, 97, 98 Surprisingly, despite its wide acceptance, the efficacy and effectiveness of CP in preventing aspiration has remained unproven and spawned debate as to its role in emergency airway management. 1, [99] [100] [101] [102] Evidence affirming a role for CP in preventing aspiration is unavailable. 1, 98, 100 Its continued use during RSI is based on anecdotal evidence and expert opinion; it has likely achieved the status of standard of care and it is unlikely that a large RCT will be forthcoming that assesses its role in high-risk patients.
In the original report assessing the anatomic basis of CP using contrast CT scanning, it was reported that only part of the esophageal lumen was obliterated when pressure was applied, even though the cricoid cartilage and cervical vertebrae were approximated. 102 In a subsequent report, cervical computed tomography scans of normal patients were reviewed to assess the anatomic relationships between the cricoid cartilage and the esophagus; lateral esophageal displacement relative to the cricoid cartilage was evident in half (25 of 51) of the patients studied; 64% of these individuals had esophageal displacement beyond the lateral border of the cricoid cartilage. 103 A later evaluation in 22 volunteers using magnetic resonance imaging reported that the esophagus was laterally displaced relative to the cricoid cartilage in 52.6% of the subjects; this proportion increased to 90.5% with the application of CP. 104 Lateral laryngeal displacement and airway compression were observed in 66.7% and 81% of the patients, respectively, with the application of CP. The potential for lateral positioning and displacement of the esophagus relative to the cricoid cartilage possibly explains a number of case reports where, despite seemingly appropriate application of CP during RSI, regurgitation and aspiration occurred nevertheless.
Cricoid pressure may interfere or prevent ventilation of the lungs with a mask and a bag as well as placement and ventilation with a laryngeal mask airway. [105] [106] [107] [108] [109] [110] Although perhaps not a major clinical issue if bag and mask ventilation is to be withheld in the induction-intubation interval, there is also evidence that maintenance of airway patency prolongs the time to desaturation even in the absence of ventilation. 78 At 44 N of applied pressure, cricoid deformation occurs in 90% of patients and 50% have airway occlusion at the level of the cricoid; 43% have cricoid occlusion at 30 N and 23% at 20 N. 111 Associated difficulty in ventilation occurs in 50% of patients. According to some RCTs, the application of CP increases the difficulty experienced during airway management with the direct laryngoscope, the lightwand, and the flexible fibreoptic bronchoscope. Less difficulty has been reported with the Bullard laryngoscope. [112] [113] [114] Although CP has been reported to make airway management more difficult, Turgeon et al. 115 were unable to confirm such an effect in an RCT of 700 patients. The view at laryngoscopy and the incidence of failed intubation at 30 sec was not different in control and cricoid pressure groups. Despite the presence of only level 5 evidence to support a role for CP during RSI, its status as a standard of care ensures its continued and routine use during RSI (Grade D recommendation). Because application of CP may result in airway obstruction and increase the likelihood of difficulty during airway management, its use is advocated primarily in situations where the risk of aspiration is high. Application of lowered pressures or release (partial or complete) of CP should be considered if it is deemed to be obstructing the airway, interfering with bag-mask ventilation, or interfering with tracheal intubation. This appears to be a supportable practice based on the same evidence (Grade D recommendation).
Should bag and mask ventilation be routinely avoided during RSI?
The practice of routinely avoiding bag and mask ventilation during RSI is based on the hypothesis that its use would result in gastric insufflation and increase the risk of regurgitation and subsequent aspiration. Avoidance of bag and mask ventilation does hasten the onset and severity of hypoxemia during RSI particularly in the setting of failed intubation. If concurrent application of CP results in some degree of airway obstruction, physiological modeling studies suggest that the onset of hypoxemia will occur earlier in the apneic interval. 78 As well, some critically-ill patients will not tolerate any duration of apnea without further desaturation. 116 Finally, routinely avoiding bag and mask ventilation will subject a significant proportion of patients to hypoxemia during the apneic interval resulting from succinylcholine administration in the setting of failed intubation. Although there is a concern that bag and mask ventilation during the interval between induction and intubation may result in gastric distension and increase the risk for aspiration, there are no data to support this contention. There is an established relationship between the airway pressures required to ventilate the lungs and those which force air into the stomach. 117 During mask ventilation without CP, airway pressures below 15 cm H 2 O rarely cause stomach inflation but pressures greater than 25 cm H 2 O do so in most patients. 118 Application of CP increases the maximum pressure reached during mask ventilation, without air entering the stomach, to about 45 cm H 2 O. 118 Application of CP also reduces gastric insufflation but may result in difficulty with ventilation in some patients and these patients tended to have more air in the stomach than those patients considered easy to ventilate. 119 Hemoglobin desaturation will occur in a proportion of patients before recovery from succinylcholine-induced apnea if airway management difficulties are encountered during RSI; a fraction of patients will be at risk regardless of the dose of succinylcholine administered and this fraction is likely increased in obese or critically ill patients (level 1b evidence). There is no evidence to support the avoidance of bagmask ventilation during the apneic interval after the induction of anesthesia to decrease the incidence of aspiration (Grade B recommendation). Keeping peak airway pressures below 15-20 cm H 2 0 will allow for ventilation without increasing the risk of air entry into the stomach (Grade C recommendation). Application of CP reduces the likelihood of gastric insufflation in most patients during bag and mask ventilation during RSI but may complicate airway management (Grade C recommendation).
Conclusions (Table II)
Aspiration of gastric contents is an uncommon complication of emergency airway management. The recommended approach to prevent aspiration and other complications during emergency airway management is the use of an RSI technique. The question of when to use or not use RSI could not be definitively answered from a review of the literature. Intuitively, patients at moderate to high risk for aspiration should be considered for an RSI technique (Grade C recommendation). If there are concerns about the ability to successfully ventilate the lungs or intubate the trachea of the patient, then avoiding RSI is prudent. The use of induction drugs and particularly NMBAs improve the success of tube placement during tracheal intubation (Grade B recommendation). Since hypotension is the most common complication after RSI, the decision to employ rapid administration of induction drugs should be carefully considered, especially in vulnerable patients, and it is a justified modification to use alternative strategies such as incremental drug administration despite a theoretical increase in the risk for aspiration (Grade D recommendation). The use of RSI as a rescue airway management strategy in the setting of failed intubation from other airway management techniques cannot be supported by existing evidence (Grade D recommendation).
Adequate preoxygenation is most rapidly achieved by TVV for at least three minutes or 8DB using fresh gas flow of 5 L·min -1 (Grade A recommendation). The routine practice of rapid administration of drugs is not recommended except in situations when the risks of aspiration are exceptionally high (Grade D recommendation). Review of the evidence does not allow recommendation of a single induction agent for all situations. Etomidate is preferable for non-septic hypotensive patients and those with limited cardiac reserve requiring RSI (Grade C recommendation). Propofol is the preferred induction drug when a nondepolarizing NMBA is used (Grade A recommendation). The NMBA of choice for RSI is succinylcholine at a dose of at least 0.6 mg·kg -1 (Grade A recommendation). Rocuronium, at a dose ≥ 0.6 mg·kg -1 , is the best alternative to succinylcholine for RSI and the use of propofol should be considered if rocuronium is to be used (both Grade A recommendations). The evidence supporting a role for the routine use of esmolol and short acting opioids in RSI is incomplete and prevents strong affirmative recommendations. The best available evidence does not support a role for lidocaine as an adjuvant drug for RSI (Grade B recommendation). Due to its low risk but potential benefit, the routine use of CP would appear to be a benign practice and it continues to be recommended (Grade D recommendation). Reduction of applied pressures during CP or its release if it is deemed to be interfering with airway management is acceptable (Grade C recommendation). The routine practice of avoiding mask-bag ventilation after the induction of anesthesia to decrease the incidence of aspiration is not recommended (Grade B). Providing bag and mask ventilation while maintaining airway pressures below 15-20 cm H 2 0 during ventilation allows for oxygenation without increasing the risk of gastric air entry and is recommended (Grade C recommendation).
Recommendations: reapplying evidence to the case After reviewing the literature, you (our physician described in the clinical scenario) conclude that the RSI technique is not necessary for all patients. In regards to the patient with the suspected subarachnoid bleed however, you decide that application of an RSI technique would likely be beneficial for her. Although her history of reflux likely has a negligible effect on increasing her risk of aspiration, the non-fasting state, her critical illness, decreased level of consciousness and increased ICP all do increase the risk, thus supporting the use of RSI.
You decide to preoxygenate her for at least three minutes of TVV since she will not be compliant to perform a DB technique. The risk of bag and mask ventilation in the induction-intubation interval is negligible but may provided substantial benefit to this particular patient. You therefore elect to provide bag and mask ventilation after induction as this will help oxygenate her and avoid an increase in ICP due to an increase in P a CO 2 . You decide to use CP and instruct your assistant in placement and application pressure. However, you will ask CP to be reduced or removed if you believe it is interfering with maintenance of the airway or with airway interventions.
Attenuation of the pressor response to intubation is critical but so is avoidance of hypotension in this case. Rapid bolus administration of the induction drug may cause hypotension to threatening levels thus a reasonable approach may be to have a slower titration of the induction drug followed by a bolus administration of a NMDA. You choose to add an adjuvant drug such as fentanyl to attenuate the pressor response to intubation. The theoretical concerns of a slight increase in ICP with succinylcholine are secondary compared with the guarantee of avoiding coughing and the excellent intubation conditions that succinylcholine provides and you elect to administer succinylcholine as the NMDA.
The selective use of RSI, with or without modification of any of its components, awaits further research to provide a more evidence-based approach to guide its use. Until then, the best strategy would appear to use an evidence-based evaluation of each aspect of an RSI technique to determine its applicability in the situations where it is to be intended. (44) 32 from 31 keep 1-44 (44) *The format of each line is: search number, key words and number of articles found in parentheses. tw = text word; pt = publication type; ti = title; random$ = truncation.
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APPENDIX 2 Levels of evidence
Level
Supporting evidence 1a Systematic review (with homogeneity) of randomized controlled trials 1b
Randomized controlled trials (with narrow confidence intervals) 2a
Systematic review (with homogeneity) of cohort studies 2b
Cohort study or low quality randomized controlled trial 3a
Systematic review (with homogeneity) of case-controlled studies 3b
Case-controlled studies 4
Case-series or poor quality cohort and case-controlled studies 5
Expert opinion Adapted from Oxford Centre for Evidence Based Medicine. http://www.cebm.net/levels_of_evidence.asp#notes. 
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